The most commonly diagnosed blood cancers are non-Hodgkin lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and multiple myeloma. Here’s what you need to know about each type of cancer. Non-Hodgkin lymphoma Non-Hodgkin lymphoma (NHL) is a type of cancer that forms in the lymph system, part of the body’s immune system. There … Read more
Medically reviewed by David P. Steensma, MD Myelodysplastic syndromes (MDS) are a group of diseases of the blood and marrow that result in the body being unable to produce enough healthy, mature blood cells. MDS develops when the blood stem cells found in the bone marrow become injured (i.e., they acquire a mutation in the … Read more
Bone marrow failure occurs when the bone marrow – the soft, spongy center of the bones – fails to produce enough healthy blood cells to keep up with the body’s needs.
This post originally appeared on Thriving, the Boston Children’s Hospital blog. Anna Protsiou was 5 when she was diagnosed with neuroblastoma in 2002. She remembers pain, and fruit-scented anesthesia masks that led her to stop eating cherries. She also remembers hospital arts and crafts projects. What she barely remembers is the pediatric oncologist who saved … Read more
Chronic graft-versus-host disease (GVHD) is a common and potentially life-threatening complication of stem cell transplants that use donor cells. It arises when the donor’s immune system cells treat the recipient’s body as foreign and raise an attack on certain organs and tissues, most often the skin, mouth, and eyes. The assault can interfere with organ … Read more
By Rich Rothman In September 2013, I had a bone marrow transplant that doctors advised was the only potential cure for a blood cancer known as MDS (myelodysplastic syndrome). Although we lived in New York City, we chose to have the transplant done at Dana Farber because we were impressed with everything we saw and … Read more
When Tim Conners collected his wish from the Make-A-Wish Foundation in 2012 at the age of 18, he was blind from childhood leukemia that had spread to his optic nerve. A football player and wrestler who’d never been an outdoorsman, he asked to meet Erik Weihenmayer, the first blind person to climb the Seven Summits … Read more
Treatment of blood-related, or hematologic, cancers is seizing on insights into the basic genetic wiring of cancer cells and the body’s system for finding and attacking those cells. Research presentations at the annual American Society of Hematology (ASH) meeting in December gave evidence of how broad, and rapid, the progress is. Targeted therapies, new combinations … Read more
A stem cell transplant is a procedure during which doctors either replace diseased or ineffective stem cells with healthy new stem cells or allow high-dose treatment for lymphoma, some testicular cancers, and other diseases. It is often lifesaving for patients with blood cancer and serious blood disorders. A person may need a transplant for a … Read more
Sometimes the best things are worth waiting for. Charles “Chuck” Vanada and Tobias Gillmann, connected across 3,700 miles and one life-altering procedure, can attest to that. In September 2009, Vanada – then a 48-year-old non-Hodgkin lymphoma patient – received a stem cell transplant at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), thanks to Gillmann, 34, who six … Read more
By Rich Rothman In 2013, I was facing a lengthy hospital stay after being diagnosed with a life-threatening blood cancer known as myelodysplastic syndromes (”MDS”). I had decided to proceed with a bone marrow transplant, which was thought to be the only potential cure. After being admitted to the hospital, I had intensive, round-the-clock chemotherapy … Read more
Medically reviewed by Joseph H. Antin, MD A treatment for patients with blood-related cancers and certain blood disorders, stem cell transplantation involves replacing a patient’s unhealthy blood-forming cells with healthy ones. Patients are first treated with chemotherapy, and sometimes radiation therapy, to wipe out or diminish the bone marrow and lymph nodes where cancers such … Read more
The holidays can be a happy time of family gatherings and traditions, but the combination of extended family and friends and cold and flu season can be dangerous for patients who are immunocompromised following recent stem cell transplants to treat blood cancers including multiple myeloma, leukemia, lymphoma, and related disorders. “When transplant patients leave the … Read more
By Rich Rothman I was rolling along in the summer of 2012. Having turned 60, I was working more than 50 hours a week as a litigation partner of a global law firm, playing tennis, fishing (not necessarily catching) on the rare occasions I could get away, and purporting to work out almost daily. After … Read more
A reduced-intensity stem cell transplant, also known as a ‘mini’ transplant, is a modified form of a procedure that replaces a patient’s blood-forming stem cells with those of a compatible donor. Mini-transplant patients receive lower doses of chemotherapy than are used in a full-intensity, or myeloablative, transplant, and, in general, receive no radiation therapy. The … Read more
Stem cell transplants today can be performed on some patients well into their 70s. While advances in transplant techniques and supportive care have made transplants safer for older patients, a variety of factors influence whether the procedure is right for each individual. Your care team can help determine what is best for you. What is … Read more
For Anna Heard, the fall of 2002 was a season of change. Set to move to Boston in September to begin a master’s program at Harvard T. H. Chan School of Public Health, Heard, then 29, had a routine physical in Washington, D.C., before starting the academic year. Although her bloodwork looked “a bit funny,” … Read more
Lauren Marsden joined DKMS/Delete Blood Cancer Registry during freshman orientation at St. Anselm’s College for the same reason she majored in nursing: She wanted to help others. What she couldn’t foresee then was how this decision would intersect with her own family’s experience. Two months after Lauren’s graduation in May 2014, her father was diagnosed … Read more
Mary Taber’s marathon training requires a singular focus. It is demanding, solitary, life-affirming – not unlike her treatment five years ago for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH). Taber, intranet editor at Dana-Farber, will mark five years from her March 2011 bone marrow transplant by taking to the storied Boston Marathon® route on April … Read more
Patients and Dana-Farber researchers alike welcomed this week’s Food and Drug Administration (FDA) approval of a new drug for a potentially fatal side effect of stem cell transplants. The approval means patients can receive the drug, defibrotide, as standard therapy for hepatic veno-occlusive disease (VOD) of the liver, a dangerous condition that sometimes follows transplantation … Read more